SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is drawing attention after reports that the Advent InternationalStripe consortium abandoned its proposed acquisition, removing the takeover premium and triggering a sharp selloff. Traders are divided between viewing the drop as an overreaction and buying opportunity based on PayPals cash generation and buybacks, while others expect further downside as the company faces standalone growth and competitive risks; a renewed bid remains speculative.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvells shares are drawing attention after a post-earnings selloff despite a quarterly beat and higher multi-year outlook, as traders focus on gross-margin compression, elevated valuation, and the view that Google-related AI revenue is largely embedded in guidance and ramps later. The community is divided between bears calling the reaction a repricing of overhyped expectations and bulls viewing the decline as a buying opportunity ahead of further custom-AI details at the investor day.

LightPath Technologies, Inc. engages in the design, development, manufacture, and distribution of optical and infrared components. Its products include molded glass and assemblies, infrared molded lenses, diamond turned, conventional ground and polished ground lenses and assemblies, and collimator assemblies, which are used in applications involving light detection and ranging technology. The firm supports a range of customers in the field of industrial, laser, defense, medical, telecommunications, and instrumentation. The company was founded in1985 and is headquartered in Orlando, FL.

Lightpath Technologies, Inc. - Ordinary Shares - Class A

Traders are attributing the sharp selloff to Army news widening the Stinger replacement search, which has fueled speculation that the NGSRI down-selection could be delayed or that competition may weaken LightPaths opportunity. Others view the reaction as excessive, arguing production timing is unchanged and broader demand for missile seekers and counter-drone optics could create additional design-in opportunities.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

A quarterly earnings miss, heavy investment needs, dilution concerns, and unclear guidance are driving IRENs sharp selloff despite its AI Cloud revenue overtaking bitcoin mining and contracted demand supporting the transition. Traders are split between viewing the decline as justified by execution and financing risks or as an overreaction to non-cash mining write-offs and a bullish long-term AI infrastructure outlook.

Rubrik, Inc. engages in the provision of cloud data management solutions. Its solutions include backup and recovery, VM backup, Microsoft 365, ransom ware recovery, database backup, cloud solutions, and Polaris sonar. Rubrik products include data protection, data threat analytics, data security posture and cyber recovery. The company was founded by Bipul Sinha, Arvind Jain, Soham Mazumdar, and Arvind Nithrakashyap in December 2013 and is headquartered in Palo Alto, CA.

Rubrik Inc. - Ordinary Shares - Class A

Rubrik Inc. - Class A

Strong quarterly results and raised guidance have drawn attention, but shares sold off sharply in a classic sell-the-news reaction after a substantial pre-earnings run. Bulls view the decline as profit-taking and emphasize organic ARR growth, cash generation and improving margins, while skeptics cite high expectations, slower cloud ARR growth, stock-based compensation and limited guidance flow-through.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

A strong fiscal fourth-quarter earnings beat and better-than-expected forward outlook are driving attention, with traders highlighting Affirms growth, improving profitability, and expanding BNPL usage. The community is broadly bullish, though some traders question the quality of the profit beat, valuation, credit risk, and the stocks tendency to fade after earnings-driven spikes.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Federal Reserve Chair Kevin Warshs Jackson Hole speech is the dominant catalyst, with traders parsing his comments on persistent inflation, potential rate hikes and limited forward guidance. The community is split between hawkish interpretations that could pressure equities and views that the speech is vague or effectively dovish, contributing to volatile, two-way SPY trading.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike shares surged following strong second-quarter results and a raised outlook, fueled by accelerating demand for AI-driven cybersecurity. Investors and analysts are actively discussing the company's record net-new ARR and expanding adoption of the Falcon platform.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Attention is centered on reports that Trian and Nelson Peltz have stepped back from previously rumored plans to take Wendys private, triggering a sharp selloff. Traders are divided between viewing the report as the end of the buyout catalyst and arguing that its anonymous sourcing and ambiguous wording leave room for a turnaround-driven short squeeze, while bears point to weak operating performance, reduced dividends, and withdrawn guidance.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

Speculation around Fed Chair Kevin Warshs Jackson Hole remarks and the resulting interest-rate outlook is driving attention, with traders divided over whether lower rates could support SoFi or a hawkish tone could pressure the stock. The discussion also centers on repeated resistance near the $19$20 area, with bulls anticipating a breakout and bears expecting another fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS $MRK $MRNA Why was $ABBV unable to enroll patients on Aza+VEN, the BAT for the SLS P3 Control ARM ?   
  
• while we are seeing miraculous extended survival in the SLS p3?    
$ABBV Claims they Could NOT ENROLL patients on Aza+VEN.  
    
Gps has proven Effective in preventing relapse and extending survival IN EVERY PREVIOUS TRIAL -- Including 2 Phase 2 Trials for AML Remission Maintenance.     
*Phase 3 Trial Results Imminent.     
     
Oral Aza -Onureg is the SOC for AML Patients in First Remission - achieved a MOS of 24.7 Months.     
$ABBV Conducted the VIALE-M PH3 trial Combining Oral Az w Venetoclax - it FAILED.     
GPS MOS in this Same First Remission Setting Achieved PH2 MOS &gt;67.6 Months.     
SOC: 24.7 --- GPs: &gt; 67.6      
Again Note the Key Gps Specific Immune Response.     
Onureg Ph3 and GPS P2 Patients were not Eligible for Transplant.     
6.7% of the Onureg CR1 Patients Subsequently rec&#39;d transplant.  
  
I’ve been here a long time if your interested in Money scroll my posts

Captain

Peggy Murphy

Oliver Schermuly

양이는귀여워

Chris

Ulaughing

CMSP

$SLS While we wait for Imminent Phase 3 Results, where we are seeing miraculous survival 40% of enrolled Second Remission CR2 patients surviving nearly 3 years, in a trial where survival on BAT is stated to be just 6-8 months. 
 
important note: $ABBV conducted a Phase 3 trial combing Aza+Ven, BAT for Control patients, for First Remission CR1 maintenance. 
VIALE-M Aza+Ven P3 for CR1 maintenance - FAILED 
ABBV REPORTED AN INABILITY TO ENROLL… 
• Unheard of miraculous Survival in the SlS CR2 P3  
and abbv ’says’ they can’t enroll their CR1 trial. 
Viale-T also Failed 
Verona Failed 
Opti-Aml RIT Aza+ Ven Failed 
 
 
 
$MRK $MRNA

StockTwits Web

SELLAS Life Sciences Group Inc

Abbvie Inc

Merck & Co Inc

Moderna Inc

5,500% ROI this quarter

 unable to enroll patients on Aza+VEN, the BAT for the SLS P3 Control ARM ?   
  
• while we are seeing miraculous extended survival in the SLS p3?    


 Claims they Could NOT ENROLL patients on Aza+VEN.  
    
Gps has proven Effective in preventing relapse and extending survival IN EVERY PREVIOUS TRIAL -- Including 2 Phase 2 Trials for AML Remission Maintenance.     
*Phase 3 Trial Results Imminent.     
     
Oral Aza -Onureg is the SOC for AML Patients in First Remission - achieved a MOS of 24.7 Months.     


 Conducted the VIALE-M PH3 trial Combining Oral Az w Venetoclax - it FAILED.     
GPS MOS in this Same First Remission Setting Achieved PH2 MOS >67.6 Months.     
SOC: 24.7 --- GPs: > 67.6      
Again Note the Key Gps Specific Immune Response.     
Onureg Ph3 and GPS P2 Patients were not Eligible for Transplant.     
6.7% of the Onureg CR1 Patients Subsequently rec'd transplant.  
  
I’ve been here a long time if your interested in Money scroll my posts